Explore All Access
Check if your research matches the topics covered in Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi?
- Degree of match
- Common matching concepts
- Additional journal recommendations
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi : Impact Factor & More
pISSN: 0253-2727
Share this on:
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
Topics Covered on Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Overall survival
Hematopoietic stem cell transplantation
Skin infiltration
Small intestine
Aplastic anemia
Molecular pathogenesis
Bortezomib
Diffuse large B-cell lymphoma
Imatinib
Acute leukemia
Nasal type
Fine needle aspiration cytology
Serum lactate dehydrogenase
Bone marrow
Persistent fever
Large intestine
Myeloid sarcoma
Clinical phenotype
Severe Aplastic Anemia
Daratumumab
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi Journal Specifications
Indexed in the following public directories
Scopus
| Overview | |
| Publisher | Zhongguo Yixue Kexueyuan |
One subscription packed with expert publication services and AI tools to get you published
Brought to you by 
Journal Selection Service
Benefit from our experts' recommendations of 3-5 best-suited journals, accompanied by a detailed Journal Selection report explaining the choices. Make informed decisions.
Journal Submission Service
Streamline your submission process with meticulous manuscript formatting to meet journal guidelines, crafting a tailored cover letter for the editor, and hassle-free account creation and submission
Bundle of AI tools for your research needs
Journal Finder, Paperpal, R Discovery, MindTheGraph and more
Planning to publish in Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
[Clinical study of the efficacies of ruxolitinib plus low-dose PTCY for acute GVHD prevention after haploidentical transplantation in malignant hematological diseases].
- 14 Feb 2024
- Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
[Evaluation of the efficacy and safety of intravenous infusion of ferric derisomaltose in the treatment of iron deficiency anemia: a single-center retrospective analysis].
- 14 Feb 2024
- Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
[Expert consensus on clonal screening and monitoring of complement inhibitor therapy in paroxysmal nocturnal hemoglobinuria (2024)].
- 14 Feb 2024
- Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
[Exploration and practice of novel models of cellular therapy and hematopoietic stem cell transplantation].
- 14 Feb 2024
- Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
[Clinical study of 15 cases of primary non-immunodeficient central nervous system lymphoma in children].
- 14 Feb 2024
- Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
[Short-term substitution of calcineurin inhibitors (CNI) with recombinant humanized anti-CD25 monoclonal antibody (Basiliximab) as aGVHD prophylaxis in CNI intolerant patients after allogeneic hematopoietic stem cell transplantation].
- 14 Feb 2024
- Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
[Clinical study of the efficacies of ruxolitinib plus low-dose PTCY for acute GVHD prevention after haploidentical transplantation in malignant hematological diseases].
- 14 Feb 2024
- Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
[Evaluation of the efficacy and safety of intravenous infusion of ferric derisomaltose in the treatment of iron deficiency anemia: a single-center retrospective analysis].
- 14 Feb 2024
- Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
[Expert consensus on clonal screening and monitoring of complement inhibitor therapy in paroxysmal nocturnal hemoglobinuria (2024)].
- 14 Feb 2024
- Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
[Exploration and practice of novel models of cellular therapy and hematopoietic stem cell transplantation].
- 14 Feb 2024
- Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
[Clinical study of 15 cases of primary non-immunodeficient central nervous system lymphoma in children].
- 14 Feb 2024
- Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
[Short-term substitution of calcineurin inhibitors (CNI) with recombinant humanized anti-CD25 monoclonal antibody (Basiliximab) as aGVHD prophylaxis in CNI intolerant patients after allogeneic hematopoietic stem cell transplantation].
- 14 Feb 2024
- Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Compare Similar Journals with Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Select Journals to Compare with Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Total journals - 6
You can select up to 3 Journals at a time
0 Journals Selected to compare with
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Compare journals across 7 parameters SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
Get detailed Journal comparison report on your email by signing up
FAQs on Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
How many articles did Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi publish last year? 
In 2023, Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi publsihed 212 articles.
Who is the publisher of Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi?
Zhongguo Yixue Kexueyuan is the publisher of Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi.
